- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Insider Buying
U.S. Pharmaceuticals & Biotech High Insider Buying
Results
80
8 new
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
80 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
JNJ | US$167.70 | 0.3% | 4.0% | US$401.3b | US$169.07 | PE28.7x | E7.9% | 3.0% | ||
PFE | US$26.64 | 1.5% | -6.1% | US$151.5b | US$30.89 | PE18.8x | E3.9% | 6.5% | ||
BMY | US$63.11 | 5.4% | 16.1% | US$124.0b | US$61.24 | PS2.7x | E32.6% | 3.9% | ||
MRNA New | US$35.96 | 18.8% | -67.9% | US$13.7b | US$55.05 | PS4.3x | E29.6% | n/a | ||
MEDP | US$337.41 | 5.7% | -16.3% | US$10.1b | US$344.83 | PE25.4x | E9.6% | n/a | ||
BRKR | US$47.40 | 1.4% | -48.2% | US$7.3b | US$68.42 | PE63.6x | E61.3% | 0.4% | ||
BHVN | US$27.63 | -13.8% | -50.1% | US$3.0b | US$63.47 | PB6.7x | E22.9% | n/a | ||
APGE | US$37.54 | 19.6% | -43.3% | US$2.1b | US$93.71 | PB3x | E-17.1% | n/a | ||
ETNB | US$7.15 | -19.5% | -44.5% | US$1.1b | US$29.67 | PB2.6x | E34.8% | n/a | ||
GERN New | US$1.61 | -5.8% | -24.8% | US$1.1b | US$4.50 | PS13.3x | E63.0% | n/a | ||
RCUS | US$9.41 | -10.4% | -50.5% | US$1.0b | US$31.60 | PS3.9x | E21.9% | n/a | ||
PAHC | US$23.23 | -5.3% | 84.2% | US$957.5m | US$21.00 | PE48.7x | E66.1% | 2.1% | ||
COGT | US$6.85 | -2.1% | 5.4% | US$774.9m | US$16.50 | PB5.2x | E42.0% | n/a | ||
AVDL | US$7.61 | 0.8% | n/a | US$764.3m | US$17.70 | PS4.3x | E48.3% | n/a | ||
IMNM | US$8.85 | -1.0% | -62.6% | US$763.7m | US$30.00 | PS71.4x | E19.7% | n/a | ||
ABCL New | US$2.20 | -6.8% | -55.6% | US$694.3m | US$11.86 | PS22.7x | E-10.5% | n/a | ||
SNDL | US$1.51 | -3.2% | 13.5% | US$414.2m | US$3.18 | PS0.6x | E144.4% | n/a | ||
TECX | US$21.31 | -9.0% | n/a | US$342.0m | US$85.67 | PB2.1x | E-25.0% | n/a | ||
MBX | US$8.98 | -11.4% | n/a | US$330.5m | US$37.25 | PB1.1x | E-23.5% | n/a | ||
ZBIO | US$7.06 | 6.3% | n/a | US$311.3m | US$31.83 | PB0.8x | E1.9% | n/a | ||
SEPN | US$5.87 | -3.1% | n/a | US$285.5m | US$25.67 | PS265.7x | E-20.2% | n/a | ||
VNDA | US$4.71 | -0.2% | 17.6% | US$282.8m | US$12.67 | PS1.4x | E58.3% | n/a | ||
PVLA | US$25.16 | 28.7% | n/a | US$275.5m | US$37.75 | PE-36.4x | E42.7% | n/a | ||
XOMA | US$21.16 | -1.5% | -19.5% | US$257.1m | US$79.50 | PS11.5x | E64.2% | n/a |